ShiraTronics, Inc., a private medical device company, today announced it has completed an additional Series A financing of $3 million bringing the Series A financing to a total of $36 million. The fin
LivaNova will share two abstracts focused on implantable neuromodulation technology for patients with heart failure during ACC.20/WCC Virtual.
Dynamic Technology Lab Private Ltd reduced its position in shares of LivaNova PLC (NASDAQ:LIVN) by 17.4% during the 4th quarter, according to the company in its most recent filing with the Securities
Marshall Wace North America L.P. reduced its stake in LivaNova PLC (NASDAQ:LIVN) by 44.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund ow
Stifel Nicolaus analyst Rick Wise maintained a Buy rating on LivaNova (LIVN – Research Report) yesterday and set a price
Pune, March 25, 2020 -- The global neuromodulation devices market size is projected to reach USD 9.34 billion by 2026, exhibiting a CAGR of 9.5% during the forecast period..

LivaNova (NASDAQ:LIVN) Shares Up 15%

09:16am, Wednesday, 25'th Mar 2020
LivaNova PLC (NASDAQ:LIVN) shot up 15% on Tuesday . The stock traded as high as $39.52 and last traded at $39.36, 1,273,972 shares were traded during trading. An increase of 161% from the average sess
Amalgamated Bank raised its holdings in LivaNova PLC (NASDAQ:LIVN) by 5.5% during the fourth quarter, Holdings Channel reports. The institutional investor owned 9,180 shares of the company’s stock a
Nexeon Medsystems (OTCMKTS:NXNN) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends,
Credit Suisse AG increased its stake in shares of LivaNova PLC (NASDAQ:LIVN) by 13.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commis
Envestnet Asset Management Inc. raised its stake in LivaNova PLC (NASDAQ:LIVN) by 62.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (
The "European Defibrillators Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.
LivaNova (NASDAQ:LIVN) was downgraded by investment analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research note issued to investors on Friday, BidAskClub reports.
Several brokerages have updated their recommendations and price targets on shares of LivaNova (NASDAQ: LIVN) in the last few weeks: 3/17/2020 – LivaNova was downgraded by analysts at ValuEngine from
Damien McDonald became the CEO of LivaNova PLC (NASDAQ:LIVN) in 2017. This analysis aims first to contrast CEO...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE